Compare MT & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MT | IQV |
|---|---|---|
| Founded | 1976 | 1982 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.4B | 41.3B |
| IPO Year | 1997 | 2013 |
| Metric | MT | IQV |
|---|---|---|
| Price | $55.25 | $242.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | $36.98 | ★ $242.60 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 02-05-2026 | 02-05-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 3.36 | ★ 7.30 |
| Revenue | ★ $61,095,000,000.00 | $15,904,000,000.00 |
| Revenue This Year | $1.69 | $6.15 |
| Revenue Next Year | $7.90 | $5.36 |
| P/E Ratio | ★ $15.95 | $32.78 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $23.20 | $134.65 |
| 52 Week High | $55.31 | $247.05 |
| Indicator | MT | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 80.59 | 59.64 |
| Support Level | $53.46 | $227.99 |
| Resistance Level | $54.59 | $242.99 |
| Average True Range (ATR) | 0.99 | 5.99 |
| MACD | 0.60 | -0.48 |
| Stochastic Oscillator | 99.00 | 71.71 |
ArcelorMittal SA is involved in the steel industry. The company's operating segments include North America, Brazil, Europe, India and JVs, Sustainable Solutions, Mining and Other . It generates maximum revenue from the Europe segment. Europe segment produces hot-rolled coil, cold-rolled coil, coated products, tinplate, plate, and slab. These products are sold to customers in the automotive, general, and packaging sectors as well as also produce long products consisting of sections, wire rods, rebar, billets, blooms and wire drawing, and tubular products. Geographically, it derives a majority of its revenue from United States.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.